Pekin Hardy Strauss, Inc. Gilead Sciences, Inc. Transaction History

Pekin Hardy Strauss, Inc.

$749 Million
Q3 2024

A detailed history of Pekin Hardy Strauss, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pekin Hardy Strauss, Inc. holds 6,280 shares of GILD stock, worth $584,479. This represents 0.07% of its overall portfolio holdings.

Number of Shares

6,280

Previous 5,547 13.21%

Holding current value

$584,479

Previous $380,000 38.42%

% of portfolio

0.07%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$66.59 - $83.99 $48,810 - $61,564	733 Added 13.21%	6,280 $526,000
Q2 2024 Aug 09, 2024	SELL	$63.15 - $72.88 $6,630 - $7,652	-105 Reduced 1.86%	5,547 $380,000
Q2 2023 Aug 08, 2023	SELL	$76.01 - $86.7 $6,080 - $6,936	-80 Reduced 1.4%	5,652 $435,000
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $56,461 - $81,059	-906 Reduced 13.65%	5,732 $492,000
Q3 2022 Nov 09, 2022	SELL	$59.54 - $68.01 $6,668 - $7,617	-112 Reduced 1.66%	6,638 $409,000
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $57,920 - $72,580	-1,000 Reduced 12.9%	6,750 $401,000
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $71,368 - $81,004	-1,100 Reduced 12.43%	7,750 $563,000
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $3,722 - $4,016	-55 Reduced 0.62%	8,850 $618,000
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $150,741 - $164,706	-2,375 Reduced 21.05%	8,905 $613,000
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $38,340 - $43,745	-639 Reduced 5.36%	11,280 $729,000
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $57,216 - $65,195	1,010 Added 9.26%	11,919 $694,000
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $65,577 - $82,452	-1,056 Reduced 8.83%	10,909 $689,000
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $565,337 - $656,460	-7,815 Reduced 39.51%	11,965 $921,000
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $631,936 - $809,419	10,090 Added 104.13%	19,780 $1.48 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $18,486 - $20,334	300 Added 3.19%	9,690 $630,000
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $18,561 - $20,814	-300 Reduced 3.1%	9,390 $634,000
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $173,208 - $194,038	-2,770 Reduced 22.23%	9,690 $630,000
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $65,806 - $85,873	-1,087 Reduced 8.02%	12,460 $779,000
Q3 2018 Nov 02, 2018	SELL	$71.28 - $78.92 $4,633 - $5,129	-65 Reduced 0.48%	13,547 $1.05 Million
Q2 2018 Aug 03, 2018	SELL	$64.88 - $75.68 $30,882 - $36,023	-476 Reduced 3.38%	13,612 $964,000
Q1 2018 May 01, 2018	BUY	$72.84 - $88.8 $25,494 - $31,080	350 Added 2.55%	14,088 $0
Q4 2017 Feb 02, 2018	SELL	$71.15 - $83.52 $83,316 - $97,801	-1,171 Reduced 7.85%	13,738 $0
Q3 2017 Nov 03, 2017	BUY	$72.11 - $85.47 $1.08 Million - $1.27 Million	14,909	14,909 $1.21 Million

Others Institutions Holding GILD

# of Institutions

1,942

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pekin Hardy Strauss, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pekin Hardy Strauss, Inc. with notifications on news.

Account

Pekin Hardy Strauss, Inc. Gilead Sciences, Inc. Transaction History